Peer Review History
| Original SubmissionJanuary 4, 2026 |
|---|
|
Dear Dr. Garcia, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 17 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Yang (Jack) Lu, PhD Academic Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that PLOS One has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 3. Thank you for stating the following in the Competing Interests/Financial Disclosure section: The authors have declared that no competing interests exist. We note that one or more of the authors are employed by a commercial company: GECORP a. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form. Please also include the following statement within your amended Funding Statement. “The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.” If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement. b. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc. Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: No Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: N/A Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: The discussion presented in the paper is both interesting and valuable; however, several sections require clarification and improvement, both technically and substantively. Throughout the manuscript, there are numerous typographical inconsistencies, particularly in the formatting of enumerated lists and the notation of mathematical symbols. For example, the symbol “\lambda i” (page 11) should be consistently written as “\lambda_i” to ensure mathematical correctness and readability. I recommend a thorough review of the manuscript to unify the typographical style and correct such issues. The main issue with the paper is the lack of mathematical rigor in the presentation of results. In several places, transformations are described using Python code fragments. While code can be helpful in illustrating implementation, the main body of the paper should provide formal mathematical descriptions of the formulas and transformations discussed. The code itself may be included in a later section dedicated to the simulation framework, but the theoretical part requires precise mathematical definitions and explanations. The mapping between DNA sequences and qubits, as presented (section 3.2), is currently limited to only four basic cases (the collapsed state for guanine is also not explained, how such state is constructed). Given that the space of qubits is, in principle, infinite, the current approach does not convincingly demonstrate the general applicability of the proposed simulation model. I recommend expanding this section to explain how the mapping can be generalized to arbitrary DNA sequences and to provide a more comprehensive justification for the chosen approach. Another area that requires improvement is the calculation of von Neumann (quantum) entropy. The paper does not clearly explain how such entropies are computed using DNA encoding. For instance, the statement “Each nucleotide in the DNA sequence is mapped to a complex amplitude, representing its quantum state” is not sufficiently detailed. It is unclear how the mapping from DNA to complex amplitudes is performed. I suggest providing a detailed algorithm or mathematical description of this process, accompanied by illustrative examples. In its current form, the paper requires substantial effort to clarify the text and to improve the mathematical aspects of the description of DNA encoding for quantum computation models. Introducing formal algorithms and precise mathematical explanations will facilitate future verification of the results. Nevertheless, I appreciate the valuable ideas presented in the work. The included appendix provides additional information relevant to the main text. Although the paper does not present a full mathematical analysis, the concepts introduced are interesting and merit broader dissemination. I also recommend addressing remaining technical issues, such as replacing equations presented as images with proper mathematical text, to further enhance the clarity and quality of the manuscript. Reviewer #2: Strengths: 1. Novelty and Originality: The attempt to link cosmological phenomena (universe expansion/Doppler shifts) with molecular biological aging via quantum tunneling is a highly unique and creative hypothesis. 2. Computational Transparency: The author is transparent about the "toy model" nature of the work and acknowledges significant physical limitations, such as the attenuation of 34 GHz signals by the atmosphere and tissue. 3. Statistical Rigor in Simulations: The manuscript employs a robust set of statistical comparisons (T-tests, Mann-Whitney U) between real genomic sequences and randomized controls to validate the internal consistency of the simulation results. 4. Clear Organization: The distinction between the Shannon entropy analysis, entanglement analysis, and tunneling simulations is logically structured. Issues: 1. Conflation of Sequence Statistics with Quantum Processing: The paper claims that real genomic segments exhibit distinctive dynamical signatures compared to controls. However, coding regions have specific statistical properties (codon periodicity, GC bias) that non-coding regions lack. The simulation likely amplifies these classical statistical differences. The author needs to demonstrate that the "quantum" differences are not simply artifacts of feeding different classical statistical distributions into a differential equation. The "shuffled controls" remove these statistical correlations, so a difference is expected regardless of quantum effects. 2. Fractal Antenna Terminology: The use of "DNA as a fractal antenna" is treated as a phenomenological shorthand. However, the manuscript cites controversial papers (e.g., Blank & Goodman) without critically addressing the lack of replication in the broader biophysics community regarding DNA microwave resonance. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Ziyu Wang ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
DNA as a Quantum System in Evolution PONE-D-26-00422R1 Dear Dr. Garcia, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Yang (Jack) Lu, PhD Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Changes made by the Author to the current version should be assessed as correct and improve the overall evaluation of the work. Reviewer #2: (No Response) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-26-00422R1 PLOS One Dear Dr. Garcia, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Yang (Jack) Lu Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .